Madrid, world pioneer in successfully treating a rare disease with CAR-T

CNIO

Factuality

Ownership

The Joint Clinical Research Unit of Pediatric Oncohematology IdiPAZ-CNIO, led by the oncologist Antonio Pérez Martínez, investigates “to solve the problems that appear in the clinic”, says researcher Andrés Paris. This week the group has revealed how it has successfully addressed the case of a pediatric patient with anti-MDA dermatomyositis5, a very rare autoimmune disease (one case per million inhabitants) that affects the immune system and has…

gciencia.com

Factuality

Ownership

The University Hospital La Paz managed to treat a girl with anti-MD5 dermatomiositis, a disease with an index of mortality up to 66% The article A CAR-T therapy saved a girl for the first time with a rare autoimmune disease was first published in GCencia.

EfeSalud

Factuality

Ownership

The pediatric patient treated with CAR-T has anti-MDA5-positive dermatomyositis, a rare autoimmune disease, characterized by the development of rapid and severe lung damage. The mortality rate ranges from 30% to 66% and the prevalence is one case per million inhabitants. CAR-Ts are gene modification therapies for certain immune system cells that recognize and destroy cancer. They have succeeded in treating cancer and on this occasion have been u…

redaccionmedica.com

Factuality

Ownership

For the first time in the world, Madrid's public health system has successfully treated a very rare autoimmune disease with CAR-T, a therapy for genetic modification of certain immune system cells that recognizes and destroys cancers. This new global medical milestone of health professionals in the Community of Madrid has been achieved in Hospital Universitario La Paz, with an 11-year-old girl suffering from a pathology called anti-MDA dermatomy…